Hi, welcome to the adveva support program, a place to come to for information about MAVENCLAD and lifestyle tips for living with MS.
We are now going to take a look at some important information about MAVENCLAD.
Take your time and make sure you understand.
If you have any questions, speak to your healthcare professional before taking your treatment.
You will also find more information about MAVENCLAD in the leaflets you’ll find on this website, which you can download
By enrolling in the adveva program, you will receive your personalized care plan, wellness advice and access to the adveva app.
And of course, you can always call the adveva team any time by calling 1-888-677-3243. We’re here to help.
So, let’s get to know MAVENCLAD.
MAVENCLAD is used to treat adults over 18 years of age who have relapsing-remitting multiple sclerosis and is generally recommended when you have not responded well to, or cannot tolerate, another therapy. Treatment with MAVENCLAD has been shown to reduce the frequency of relapses and slow down disability progression.
Your healthcare professional has prescribed this treatment for you based on your symptoms and test results.
MAVENCLAD tablets are white, round tablets engraved with 'C' on one side and '10' on the other.
Each tablet contains 10 milligrams of cladribine, the active ingredient of MAVENCLAD.
MAVENCLAD is taken for two weeks in the first year, then two weeks in the second year. The two treatment weeks are spaced one month apart.
Outside these treatment weeks, you will not need to take any MAVENCLAD
In Years 3 and 4, your healthcare professional will monitor your MS, and during this time you will not need to take MAVENCLAD.
To understand how MAVENCLAD works, we’ll need to refresh your understanding of what happens in MS.
In people with MS, the immune system attacks the protective covering of the nerves (known as myelin), causing inflammation and damage that can lead to the symptoms of MS.
An MRI scan can show the scar-tissue damage caused by the immune system, known as lesions.
There are several different types of immune cells in the body’s immune system. In multiple sclerosis, T and B cells, also known as lymphocytes, play a key role.
MAVENCLAD acts in a specific way on T and B cells to reduce inflammation in your body caused by MS.
MAVENCLAD is a trademark of Merck KGaA, Darmstadt, Germany or its affiliates.